Taisho Pharmaceutical Holdings News

TAIPYDelisted Stock  USD 14.00  0.00  0.00%   
Slightly above 56% of Taisho Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Taisho Pharmaceutical Holdings pink sheet suggests that many investors are alarmed at this time. Taisho Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, Taisho Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
  
over three months ago at news.google.com         
Japans Taisho Pharma faces claim over buyout price from Curi RMB, Oasis - Nikkei Asia
Google News at Macroaxis
over three months ago at news.google.com         
Japans Taisho Pharma faces claim over buyout price from Curi RMB, Oasis - Nikkei Asia
Google News at Macroaxis
over three months ago at news.google.com         
Taisho Pharmaceutical Trading Up 16.7 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Moodify Ltd announced that it has received 8 million in funding from The Procter Gamble Company, Toy...
Google News at Macroaxis
over six months ago at news.google.com         
Taisho Pharmaceutical Stock Price Up 0.1 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Taisho Pharmaceutical Trading Up 1.5 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Oasis Management Send a Notice to Taisho Pharmaceutical Holdings Co., Ltd - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Curi RMB Capital Opposes Taisho Pharmaceutical HDs Management Buyout - Business Wire
Google News at Macroaxis
over six months ago at news.google.com         
Oasis says it opposes Taisho Pharmas 5 bln management buyout - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Management buyouts by big companies on rise in Japan - The Japan Times
Google News at Macroaxis
over a year ago at news.google.com         
Mizuho sees urgency as Japan Inc scurries to bolster capital in line with TSE - KFGO
Google News at Macroaxis
over a year ago at news.google.com         
Weekly Top Ten Event-Driven and Index Rebalance - Nov 30, 2023 - Smartkarma
Google News at Macroaxis
over a year ago at news.google.com         
Weekly Top Ten Event-Driven and Index Rebalance - Nov 29, 2023 - Smartkarma
Google News at Macroaxis
over a year ago at news.google.com         
Weekly Top Ten Event-Driven and Index Rebalance - Nov 28, 2023 - Smartkarma
Google News at Macroaxis
over a year ago at news.google.com         
Japans Nikkei surrenders early gains as investors lock in profits - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Taisho Pharmaceutical that are available to investors today. That information is available publicly through Taisho media outlets and privately through word of mouth or via Taisho internal channels. However, regardless of the origin, that massive amount of Taisho data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Taisho Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Taisho Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Taisho Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Taisho Pharmaceutical alpha.

Taisho Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Taisho Pink Sheet

If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities